The biotech's Phase 2a study of bempikibart showed a 35.3% mean reduction in hair loss scores, with the company planning a ...
MedPage Today on MSN
JAK and IL-23 Inhibitors for Ulcerative Colitis: Making Decisions About Dosage
New data suggest more is better, but choices come with tradeoffs ...
A new pilot program for adults with Medicare Part D coverage will cut the price of Wegovy, Zepbound, and Foundayo. Find out ...
Even when he was a child, Sean Ianchulev, MD, MPH, wanted to fix things and make them better.When he emigrated to the United ...
Technology, rising costs, and other factors have changed the face of doctor-patient relationships. But physicians remain ...
Federal court revives 550 Tylenol lawsuits, reinstating expert testimony on prenatal use linked to autism and ADHD in New York cases.
Everyday Health on MSN
Coffee may lower the risk of serious liver disease
A new study of more than 350,000 people suggests coffee, regular and decaf, may protect against serious liver ailments. Learn ...
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, ...
Explore the growing financial cost of cardiovascular disease in the US and the relationship between economic strain and ...
Almost 50% of all dementia cases could be prevented through modifiable risk factors, research shows, but we need better ways ...
Considered the founder of molecular epidemiology, he worked with Frederick P. Li to identify a hereditary disorder that increased the risk of developing cancer at a young age. By Trip Gabriel Dr.
Range Impact, Inc. (OTC: RNGE) (“Range Impact” or the “Company”), a public company dedicated to acquiring, reclaiming and repurposing former industrial and mine properties throughout Appalachia, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results